(October 9, 2025)
Back on October 2, 2025, we released our WVE (Wave Life Sciences Ltd.) Stock Options Analysis highlighting a textbook setup for a volatility-based swing trade. The charts showed RSI building strength off the mid-40s and MACD flipping bullish — perfect conditions for a short-term upside breakout.
At that time, we entered a position at $0.33 per contract and advised readers to set a Good-Til-Canceled (GTC) sell-to-close order targeting an 80% profit, which would trigger automatically at $0.60 per contract.
Fast-forward just seven days later — October 9, 2025 — that GTC order was hit automatically, closing the position for an 81.8% gain.
This move proves once again how disciplined execution, when combined with the right technical setup, can produce extraordinary returns in a very short period.
📊 Before and After: Chart Comparison
October 2, 2025 – Original Setup
During the initial setup, WVE was quietly consolidating between $6.80–$7.20, forming a bullish divergence on RSI while volume began increasing. The MACD lines were curling upward, signaling early institutional accumulation — exactly the type of environment our 12-Pillar Alpha+ Framework is designed to detect before the crowd notices.
October 9, 2025 – GTC Profit Hit
By October 9, WVE surged above $8.00, pushing RSI into the mid-70s and confirming bullish momentum. Volume more than doubled, MACD showed strong continuation, and traders who had preset their sell levels were automatically taken out of the position right near the high of the move.
💵 Profit in Perspective
Let’s look at what that actually means in dollar terms — because this is where the power of options leverage becomes very real.
If you had followed the original analysis and bought:
- 300 contracts (each controlling 100 shares) at $0.33, your initial investment would be $9,900.
- When the GTC sell order executed at $0.60, those contracts would be worth $18,000.
- That’s a profit of $8,100 in just one week — automatically triggered without needing to watch the chart every day.
Scale that position up to 500 contracts, and the profit balloons to $13,500.
💬 Had you listened to our previous article and entered a position, you would have automatically profited this much — a clean, hands-free double-digit-thousand gain in only seven days.
These results show why having a plan in place — with a predetermined profit target — removes emotion and allows disciplined traders to capture moves with surgical precision.
🧭 Technical Recap & Market Context
This rally came as biotech and RNA-based therapeutics stocks caught renewed attention in early October. With the sector rebounding off September lows, liquidity and speculative capital rotated back into smaller-cap gene-therapy names such as WVE.
Technically:
- RSI spiked to 76, confirming overbought momentum but validating the strength of the move.
- MACD remained positive and wide-spread, showing strong bullish energy at the peak.
- Price Action: The underlying stock moved from roughly $7.00 to $8.20, a 17% rise — but the options amplified that move by nearly five times.
From a trader’s perspective, this setup perfectly demonstrates how a small directional edge combined with leveraged exposure can yield institutional-grade returns in days, not months.
⚠️ Disclaimer
This article is for informational and educational purposes only and does not constitute financial or investment advice. Options trading involves significant risk, including the potential loss of your entire investment. Past performance is not indicative of future results. Always do your own due diligence and consult a licensed financial advisor before entering any trade.
🧩 Summary
| Metric | Value |
|---|---|
| Entry Date | October 2, 2025 |
| Exit Date (GTC hit) | October 9, 2025 |
| Entry Price (per contract) | $0.33 |
| Exit Price (per contract) | $0.60 |
| % Gain | +81.8% |
| Example Profit (300 contracts) | +$8,100 |
| Holding Period | 7 days |
| Position Type | LEAPS Call Option |
✅ Key Takeaway
The WVE trade illustrates the power of pre-planned profit targets and automated exits. Traders who acted on our original October 2 analysis didn’t need luck — they needed discipline.
When technical momentum, proper risk sizing, and patience align, even a modest-sized position can turn into five-figure profits — without constant monitoring or emotional decision-making.
